Specific Recognition of Thymic Self-Peptides Induces the Positive Selection of Cytotoxic T Lymphocytes  by Hu, Qinghui et al.
Immunity, Vol. 7, 221±231, August, 1997, Copyright 1997 by Cell Press
Specific Recognition of Thymic Self-Peptides
Induces the Positive Selection
of Cytotoxic T Lymphocytes
Qinghui Hu,*² Carthene R. Bazemore Walker,‖ referred to as the ªthymic paradoxº is how the similar
Cristina Girao,* Joseph T. Opferman,*³ interactions that take place between TCRs and self-
Jiling Sun,*² Jeffery Shabanowitz,‖ Donald F. Hunt,‖# peptide/MHC complexes trigger two very different cell
and Philip G. Ashton-Rickardt*²³§ fates during the two types of selection, and so give rise
*Gwen Knapp Center for Lupus and to T cells that recognize MHC-restricted antigen but are
Immunology Research largely tolerant to self.
²Department of Pathology To address this issue, the nature of the ligand that
³Committee on Immunology triggers positive and negative selection has been inves-
§Committee on Developmental Biology tigated in experiments using cultured fetal thymi from
University of Chicago class I MHC±deficient mice (Ashton-Rickardt et al.,
Chicago, Illinois 60637 1993, 1994; Hogquist et al., 1993, 1994; Sebzda et al.,
‖Department of Chemistry 1994). In TAP1 (transporter associated with antigen
#Department of Pathology processing 1) mutant mice, the major route of class I
University of Virginia MHC peptide loading, in the endoplasmic reticulum, is
Charlottesville, Virginia 22903 blocked (Attaya et al., 1992; Van Kaer et al., 1992; Shep-
herd et al., 1993). Consequently, surface expression of
MHC class I molecules is reduced, and positive selection
Summary of CD81 T cells is severely hampered (Ashton-Rickardt
et al., 1993). Only a few ªempty,º ill-folded class I mole-
To understand how thymic selection gives rise to T cules appear on the surface of cells in TAP1 mutant
cells that are capable of major histocompatibility com- mice. These empty class I molecules can be loaded and
plex (MHC)±restricted recognition of antigen but are stabilized with peptides when provided extracellularly
tolerant of self, we directly examined how peptide/ in the presence of b2-microglobulin (Van Kaer et al.,
MHC ligands expressed on thymic epithelial cells trig- 1992). The addition of antigen peptides, or antigen vari-
ger the positive selection of immature thymocytes. ants, to fetal thymus organ cultures (FTOC) from TAP12
We demonstrate that abundant self-peptides, purified mice restored the stable expression of peptide/MHC
from the H-2Db molecules of thymic epithelial cells, are class I complexes on the surface of thymic stromal cells
specifically recognized during the positive selection of (Ashton-Rickardt et al., 1993). The relative ability of
CD81 T cells, implying that positive selection gener-
these peptides to induce the positive selection of CD81
ates a repertoire of T cells that is weakly self-reactive. T cells depends on the relative density of peptide/class
Wealso found that this recognition is somewhat cross-
I MHC complexes on TAP12 thymic stromal cells andreactive, thereby providing an explanation for how the
on the structure of the peptide. This implies that peptidespecific recognition of a limited repertoire of thymic
is specifically recognized during the positive selectionself-peptides can select a diverse repertoire of T cells.
of CD81 T cells (Ashton-Rickardt et al., 1993, 1994).
On the basis of these observations, it has been sug-Introduction
gested that thymic self-peptides may bespecifically rec-
ognized during the positive selection of CD81 T cellsDuring thymic development the repertoire of antigen
and that the repertoire of cytotoxic T lymphocyte (CTL)±specificities displayed by T cells is shaped by the pro-
antigen specificities is shaped by the repertoire of self-cesses of positive and negative selection (von Boehmer
peptides expressed in the thymus. To test this hypothe-et al., 1989). These selection events generate an immune
sis, we purified several peptides from H-2Db moleculessystem that is able to respond to a vast universe of
expressed by mouse thymic epithelial cells and testedpathogens and also to discriminate between self and
their ability to induce the positive selection of CD81 Tnonself. Positive selection (Bevan, 1977) ensures that T
cells. Transgenic mice that express either a TCR (F5,cells leaving the thymus are capable of major histocom-
Va4, Vb11) specific for the influenza 1968 virus (IF-68)patibility complex (MHC)±restricted recognition of anti-
nucleoprotein (366±374) presented by H-2Db (Townsendgenand thusare capableof recognizingantigen presented
et al., 1986; Mamalaki et al., 1992), or a TCR (P14, Va2,in the peptide-binding cleft of self-MHC molecules (Zink-
Vb8.1) specific for the lymphocytic choriomeningitis vi-ernagel and Doherty, 1974; Bjorkman et al., 1987). Posi-
rus (LCMV) glycoprotein peptide (33±41) presented bytive selection is triggered by the engagement of T cell
H-2Db (Pircher et al., 1989, 1990), were crossed to TAP1-receptors (TCRs) on immature TCR1hiCD41CD81 thymo-
deficient mice to generate P14 TAP12 and F5 TAP12cytes with self-peptide/MHC molecules expressed by
mice.thymic epithelial cells (Lo and Sprent, 1986; Anderson et
Although all thymic self-peptides tested could effi-al., 1993). Negative selection eliminates, through clonal
ciently stabilize the surface expression of H-2Db mole-deletion, those T cells that are potentially autoreactive
cules onTAP12 thymic stromal cells, there was a marked(Schwartz, 1989) and is thought to involve engagement
difference in their abilities to induce the positive selec-of TCRs on immature thymocytes with self-peptide/
tion of polyclonal CD81 thymocytes. Furthermore, weMHC molecules expressed on the surface of bone mar-
found that these self-peptides triggered the positive se-row±derived thymic stromal cells (von Boehmer and Ha-
lection of anti-IF-68 or anti-LCMV CTL precursors infen, 1984; Kisielow et al., 1988). One of the central ques-
tions that remains to be solved and that is sometimes TAP12 FTOC, but not both. These findings support the
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Figure 1. Chromatography of Peptides Eluted
from H-2Db Molecules of 427.1 Cells
Peptides from anti-H-2Db affinity columns
(H-2Db) or mock extracts (H-2Dd) were re-
solved by C18 narrow-bore RP-HPLC. Pep-
tides in RP-HPLC fractions from peaks
unique to H-2Db chromatographs (arrows; as-
terisk, pooled fractions 37 and 38) were fur-
ther analyzed.
view that self-peptides are specifically recognized dur- In the representative experiment shown in Figures 1
and 2, peptides from RP-HPLC fractions 37 and 38 froming the positive selection of CTL precursors in the thy-
mus, but that this recognition is relatively degenerate H-2Db affinity columns and mock extracts were analyzed
by microcapillary HPLC and electrospray ionization massand gives rise to a repertoire of T cells that is shaped by
the repertoire of self-peptides expressed in the thymus. spectrometry. An ion at a mass-to-charge ratio (m/z) of
541 is present in the H-2Db±derived material (Figure 2A)
but absent in the mock extracts (Figure 2B), indicatingResults
that the material isolated from 427.1 cells was specifi-
cally associated with the H-2Db molecules. To obtainPurification of Self-Peptides from a Thymic
Epithelial Cell Line sequence information, (M12H)21 ions at m/z 541 were
subjected to collision-activated dissociation on the tri-We chose to use the thymic epithelial cell line 427.1
(Brinster et al., 1984; Faas et al., 1993) (H-2b/s) as a source ple-quadrupole mass-spectrometer (Hunt et al., 1992).
The resulting data and deduced sequence FQXVNPHXXof class I MHC because the H-2b molecules expressed
on the surface of this cell line can induce the positive are shown in Figure 2C. The letter X represents either
leucine or isoleucine, two amino acids of identical massselection of H-2Kb± and H-2Db±restricted CTLs when
injected into the thymi of mice (Vukmanovic et al., 1992). that cannot be distinguished on the triple-quadrupole
instrument. Comparison of this sequence with proteinTherefore in our experiments 427.1 cells were used as
starting material for the purification of H-2Db±associated sequences in the GenBank database revealed that
the deduced sequence matches residues 634±642self-peptides that trigger the positive selection of CD81
T cells. We immunopurified H-2Db molecules from deter- (FQIVNPHLL) of murine ribonucleotide reductase (En-
zyme Code 1.17.4.1) M1 subunit (Thelander and Berg,gent extracts of 427.1 cells using immobilized, anti-H-
2Db monoclonal antibodies (MAbs) B22±249R1 (Town- 1986).
Table 1 shows a list of peptides that have been elutedsend et al., 1989) (a1-domain specific) or 28±14±8S
(a3-domain specific [Zijlstra et al., 1990]). Using this from H-2Db molecules expressed by 427.1 thymic epi-
thelial cells. Complete sequences of six peptides in Ta-procedure, we were able to purify between 0.75 and 1.5
nmol of peptide/H-2Db complexes from 1010 427.1 cells, ble 1 have been obtained, three of which found matches
with mouse proteins in database searches. With theas estimated by SDS±polyacrylamide gel electrophore-
sis analysis (data not shown). The associated peptides exception of peptide 3, all of the peptides are nine amino
acids long and contain the characteristic H-2Db anchorwere released by acid extraction and separated from
H-2Db molecules and antibody by filtration and then residues of asparagine (N) at position5 and either isoleu-
cine (I) or leucine (L) at position 9 (Falk et al., 1991;resolved by narrow-bore, reverse-phase high-pressure
liquid chromatography (RP-HPLC) (Figure 1). Detergent Young et al., 1994). Peptide 3 is from the SV40 virus
large T protein (amino acids 206±215) and is presentextracts of 427.1 cells were also passed through col-
umns containing an irrelevant anti-H-2Dd MAb (34±2± because the SV40 protein was used to transform thymic
cells in transgenic mice harboring the SV40 large T gene12S [Ozato et al., 1982]) to make negative-control mock
extracts, which were also analyzed by RP-HPLC. Pep- (Brinster et al., 1984). Peptides 4 and 5 found database
matches with nonmouse proteins, presumably becausetides present in fractions eluting in chromatograph
peaks from H-2Db affinity column separations, but ab- the equivalent mouse protein sequences are not present
in the database. Peptides 1, 2, and 6 are derived fromsent in the same fractions from mock extracts, were
further analyzed by the combination of microcapillary normal mouse proteins and are expressed at relatively
high abundance. Peptide 2 is the most abundant peptideHPLC and triple-quadrupole tandem mass spectrometry
(Hunt et al., 1992). we isolated and is present at between 7% and 13%
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Figure 2. Purification of H-2Db±Associated Self-Peptides from 427.1
Cells
(A and B) Plots of total ion current obtained in each mass spectrum
recorded on 1/25 of the material in the pooled RP-HPLC fractions
37 and 38 from anti-H-2Db (A) and anti-H-2Dd mock extracts (B).
Mass spectra were recorded on a triple-quadrupole mass spectrom-
eter equipped with an electrospray ion source and a C-18 microcap-
illary-HPLC column. The mass range, m/z 300±1400, was scanned
repetitively every 1.5 sec, and the total ion signal in each spectrum
was summed. Insets are plots of the ion current for the peptide
(M12H)21 at m/z 541 (nominal mass).
(C) Collision-activated dissociation mass spectrum of peptide
(M12H)21 ions at m/z 541. Predicted masses for fragment ions of
types b and y are shown above and below the deduced amino acid
sequence (Hunt et al., 1986). Ions observed in the spectrum are
underlined. Subtraction of m/z values for any two fragments that
differ by a single amino acid generates a value that specifies the
mass and thus the identity of the extra residue in the larger fragment.
Since isoleucine and leucine are of identical mass, they cannot be
differentiated on the triple-quadrupole instrument and are specified
as Lxx. O indicates ions that represent single losses of water.
of total peptide/H-2Db molecules on 427.1 cells. The
relatively high abundance of this peptide (referred to
as RR hereafter) was observed in material from two
independent affinity purifications of H-2Db from 427.1
cells with B22±249R1 MAb and once with 28±14±8S
MAb. The ribonucleotide reductase M1 subunit is essen-
tial for DNA synthesis and cell division and is highly
expressed in the thymus (Thelander et al., 1980). Peptide
6 is from histone H2A.1 (Fecker et al., 1990) (amino acids
76±84) and is present at between 2% and 4% of total
peptide/H-2Db molecules (referred to as HH hereafter).
Histone H-2A.1 is widely expressed in all tissues be-
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cause it is essential for cell viability (Fecker et al., 1990).
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Table 2. Relative Abilities of Peptides to Stabilize Surface H-2Db and to Stimulate F5 and P14 CTLs
50max H-2Db 50max F5 50max P14
Peptide Sequence (M) (M) (M)
BP NSIRNLDTI 1 3 1027 .1 3 1025 .1 3 1025
RR FQIVNPHLL 2 3 1025 .1 3 1025 .1 3 1025
HH LAIRNDEEL 2 3 1026 .1 3 1025 .1 3 1025
IF-34 ASNENMETM 2 3 1026 .1 3 1025 .1 3 1025
IF-68 ASNENMDAM ND 1 3 1028 .1 3 1025
LCMV KAVYNFATM 1 3 1024 .1 3 1025 7 3 1029
The relative ability of peptides to stabilize H-2Db molecules is expressed as the 50max H-2Db value and is defined as the concentration of
peptide required to rescue the surface expression of H-2Db on the surface of RMA-S cells to a level that is 50% of the maximum (maximum
being about 35% of RMA) in an overnight in vitro experiment. The relative ability of peptides to sensitize RMA (H-2b) target cells to lysis by
either F5 or P14 CTLs in 51Cr-release assays is expressed as the 50max P14 or 50max F5 value. This is defined as the concentration of peptide
necessary to give 50% of the maximum specific lysis of RMA-peptide in CTL assays, with the maximum being about 60% specific lysis.
ND, data not determined.
The proteins from which RR and HH are derived are Having demonstrated that H-2Db surface expression
can be restored by exogenously provided self-peptideslikely to be essential for the growth and development
in TAP12 FTOC, we wanted to find out whether theof the thymus, implying that as well as being expressed
production of TCR1hi CD42CD81 (referred to as CD81on 427.1 cells these self-peptides are also expressed
cells hereafter) is also restored in these organ cultureson stromal cells from normal H-2b thymi. Peptide 1 is
by self-peptide treatment. Our data indicate that CD81present at between 3% and 6% of total peptide/H-2Db
cell levels are raised by one of the three self-peptidesand corresponds to brain protein E46 (amino acids 100±
tested (Figure 3). We observed that the addition of RR108), which is predicted to be encoded by a cDNA iso-
(at 300 mM) to TAP12 FTOC induced the positive selec-lated from mouse brain (referred to as BP hereafter). We
tion of CD81 cells to a level of about 62% of that ob-have detected theexpression of brain proteinE46 mRNA
served in TAP11 FTOC, but the addition of HH and BPin thymic stromal cells from C57BL/6 mice (data not
at the same concentration did not give rise to any signifi-shown), which suggests that the purification of BP pep-
cant increase in the number of CD81 cells. We havetide from 427.1 cells reflects in vivo expression of the
shown previously that the increase in CD81 cell numbergene in the thymus. The expression of HH, BP, and RR
during positive selection is due to the differentiation ofon 427.1 cells counts for up to 23% of total self-peptide/
multiple different thymocyte precursors rather than theH-2Db expression. Therefore, to assess the true in vivo
proliferation of a few precursors (Ashton-Rickardt et al.,role of self-peptides in T cell selection, we examined
1993, 1994).the ability of these peptides to induce the positive selec-
Therefore we conclude that the expression of RR ontion of CD81 T cells.
thymic stromal cells leads to the positive selection of a
larger repertoire of CD81 cells than the expression ofThymic Self-Peptides and the Positive
BP or HH. Furthermore, the data imply that the abilitySelection of CD81 T cells
of a self-peptide to drive the positive selection of CD81To examine the specificity of self-peptide recognition
cells is not based solely on its ability to stabilize MHC
during positive selection, we tested the ability of several
class I molecules on the surface of selecting cells.
abundant, thymic self-peptides to restore the positive
selection of CD81 T cells in TAP12 FTOC. We first esti-
Table 3. Relative Abilities of Peptides to Stabilize Surface H-2Dbmated the relative affinity of the thymic self-peptides HH
on TAP12 Thymic Stromal Cells(LAIRNDEEL), BP (NSIRNLDTI), and RR (FQIVNPHLL) for
H-2DbH-2Db molecules, by determining the ability of peptides
FTOC Peptide Levelto stabilize H-2Db expression on the surface of TAP
2±deficient RMA-S cells (Ljunggren and Karre, 1985; TAP11 Ð 100
Attaya et al., 1992). As shown in Table 2, BP stabilized TAP12 Ð 0
TAP12 IF-34 35surface H-2Db molecules better than the IF-34 peptide
TAP12 HH 40(ASNENMETM), which has a relatively high affinity for
TAP12 BP 64H-2Db (Sigal et al., 1995). The HH peptide was about as
TAP12 RR 27
effective as IF-34, and RR was less effective than IF-
The surface expression of H-2Db, on gated I-Ab1 thymic stromal34. We then determined the relative level of H-2Db ex-
cells, from TAP11 and TAP12 FTOC, incubated with or without pep-pression induced by thymic self-peptides on the surface
tide (300 mM) for 3 days, was quantitated by determining the mean
of thymic stromal cells in TAP12 FTOC. As shown in fluorescence intensity resulting from staining of cells with anti-H-2Db
Table 3,all three self-peptides (at 300 mM) were relatively Mab (B22-249R1). The degree of rescue of H-2Db by peptide on
potent in their ability to stabilize H-2Db molecules on thymic stromal cells is expressed as a percentage of the TAP11
value, less the background level from TAP12 FTOC incubated with-TAP12 I-Ab1 thymic stromal cells. The BP self-peptide
out peptide. Similar results were obtained in a separately performedwas the most effective (64% of TAP11 level), followed
experiment.by HH (40% of TAP11 level) and RR (27% of TAP11
level).
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TAP11 thymi (21%) as shown in the representative ex-
periment in Figure 4A. As observed previously (Ashton-
Rickardt et al., 1994), when we cultured day 16 fetal
thymic lobes from P14 TAP12 mice (hereafter referred
to as P14 TAP12 FTOC) or P14 TAP11 mice (hereafter
referred to as P14 TAP11 FTOC) for 8 days, we observed
fewer CD81P14 thymocytes from TAP12 thymi (1%)
compared to TAP11 thymi (15%), as shown in the repre-
sentative experiment in Figure 4B.
The ability of the thymic self-peptides to induce the
positive selection of either CD81 F5 in F5 TAP12 FTOC
or CD81 P14 cells in P14 TAP12 FTOC was tested. We
found that the addition of HH and BP (at 300 mM) to F5
TAP12 FTOC led to the accumulation of F5 CD81 cells,
but the addition of RR at the same concentration had
no significant effect on F5 CD81 cell number (Figure 5A).
Figure 3. Some but Not All Self-Peptides Induce the Positive Selec- However, we found that RR (at 300 mM) induced the
tion of CD81 Cells positive selection of CD81 P14 cells inP14 TAP12 FTOC,
The ability of thymic self-peptides (HH, BP, and RR) to restore the whereas HH and BP did not (Figure 5B). Although the
positive selection of CD81 cells was tested in TAP12 FTOC. Thymo- level of CD81 cell rescue in F5 TAP12 and P14 TAP12
cytes from TAP11 and TAP12 FTOC were analyzed for the surface
FTOC was relatively low, data from several experimentsexpression of CD8, CD4, and pan-TCRb chain by MAb staining and
indicated that HH, BP, and RR differentially restored theFACS. Thymocytes that were CD42CD81 were gated and analyzed
positive selection of CD81 F5 and CD81 P14 cells (Figurefor the surface expression of pan-TCRb, and then the overall per-
centage of CD42CD81 TCR1hi cells was determined (CD81 cells). The 6). We examined the ability of the self-peptides to
levels indicated are based on the analysis of three to five separately sensitize target cells to lysis by P14 and F5 CTLs in
cultured lobes (mean 6 SEM). Addition of either HH or BP (300 mM) 51Cr-release assays. As shown in Table 2, none of the
did not result in significant changes in the number of CD81 cells
thymic self-peptides tested were able to directly stimu-(p . 5%) but the addition of RR (300 mM) did (1% . p . 0.5%).
late either P14 or F5 CTLs in agonist assays, suggest-
ing that they have a relatively low affinity for the F5 and
P14 TCRs.
Thymic Self-Peptides and the Positive Selection These data indicate that the recognition of self-pep-
of Transgenic TCR CD81 T Cells tides during the positive selection of CD81 cells is spe-
We wanted to examine the relative ability of self-pep- cific for the TCR expressed by a given thymocyte.There-
tides to induce the positive selection of individual T cell fore we conclude that the positive selection of CD81
clones with defined antigen specificity. The precursor cells can be induced by the specific recognition of low-
frequency of class I MHC±restricted antiviral T cells in affinity self-peptides when expressed at a high density
the thymus is relatively low (about 1 in 40,000) (Owen on thymic stromal cells.
et al., 1984), making it difficult to measure directly the
ability of self-peptides to positively select these T cells Thymic Self-Peptides and the Positive
in a polyclonal FTOC system. Therefore we examined Selection of Anti-Viral CTLs
the role of self-peptides on the positive selection of two To examine whether the F5 CD81 and P14 CD81 thymo-
different H-2Db±restricted CD81 TCR transgenic thymo- cytes, selected by thymic self-peptides in TAP12 FTOC,
cyte populations, one of which specific for a peptide were capable of giving rise to functional T cells, we
from the IF-68 nucleoprotein (amino acids 366±374) employed a limiting dilution analysis method, which al-
(ASNENMDAM) (Townsend et al., 1986) and another lowed us to quantitate the number of antigen-reactive
specific for a peptide from the LCMV glycoprotein CTL precursors produced in FTOC (Ceredig et al., 1982).
(33±41) (KAVYNFATM) (Pircher et al., 1987). Transgenic Thymic self-peptides were incubated with either F5
mice (P14) (Pircher et al., 1989) expressing a TCR (Va2, TAP12 FTOC or P14 TAP12, and the number of F5 CD81
Vb8.1) specific for LCMV were crossed with TAP1-defi- or P14 CD81 cells was quantitated. Limiting dilutions of
cient mice. The positive selection of Va21hi Vb8.11hi thymocytes from fetal thymic lobes were subsequently
CD42CD81 (referred to as CD81 P14 cells hereafter) cocultured with the appropriate antigen peptide for 7
cells is severely impaired in P14 TAP12 mice (Ashton- days and then assayed for cytolytic activity to 51Cr-
Rickardt et al., 1994). Transgenic mice (F5) (Mamalaki labeled targets incubated with the same antigen. Esti-
et al., 1992) expressing a TCR (Va4, Vb11) specific for mates of CTL precursor frequencies were determined
the IF-68 were crossed with TAP1- and RAG-1±deficient by analyzing the Poisson distribution of the data, which
mice (Mombaerts et al., 1992) to generate F51/1 TAP12/2 allowed us to then determine the percentage of CTL
RAG12/2 mice (referred to as F5 TAP12 mice hereafter), precursors in thymic lobes. The representative experi-
which express only F5 TCR chains on the surface of ments shown in Table 4 indicate that the frequency of
thymocytes. When day 16 fetal thymic lobes from F5 IF-68±specific CTL precursors was about 25-fold lower
TAP12 (hereafter referred to as F5 TAP12 FTOC) or F5 in F5 TAP12 FTOC (0.05%) compared toF5 TAP11 FTOC
TAP11 mice (hereafter referred to as F5 TAP11 FTOC) (1.25%), and that the frequency of LCMV-specific CTL
were cultured for 9 days, we recovered fewer F5 CD81 precursors was about 25-fold lower in P14 TAP12 FTOC
(0.33%) compared to P14 TAP11 FTOC (8.33%).thymocytes from TAP12 thymi (1%) compared with
Immunity
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Figure 4. Addition of Self-Peptides to TAP12 FTOC Restores the Positive Selection of Transgenic CD81 Thymocytes
(A) The positive selection of CD81 F5 cells is impaired in fetal thymi from F5 TAP12 mice. Thymocytes from F5 TAP11 and F5 TAP12 FTOC
were analyzed for the surface expression of CD8, CD4 and TCR Vb11 by MAb staining and FACS. Thymocytes that were CD42CD81 were
gated and analyzed for the surface expression of TCR Vb11, and then the overall percentage of CD42 CD81 TCR Vb111hi (CD81 F5 cells) was
determined. The percentage of CD81 F5 cells was reduced in F5 TAP12 (1%) compared to F5 TAP11 (21%) FTOC. The percentage of CD81
F5 cells could be partially restored by the addition of HH (3%) and BP (6%) peptides at 300 mM to F5 TAP12 FTOC. Similar results were
obtained in four other separately performed experiments.
(B) The positive selection of CD81 P14 cells is impaired in fetal thymi from P14 TAP12 mice. Thymocytes from P14 TAP11 and P14 TAP12
FTOC were analyzed for the surface expression of CD8, CD4, TCR Va2, and TCR Vb8.1 by MAb staining and FACS. Thymocytes that were
CD42CD81 were gated and analyzed for the surface expression of TCR Va2 and TCR Vb8.1, and then the overall percentage of CD42CD81
TCR Va21hi TCR Vb8.11hi (CD81 P14 cells) was determined. The percentage of CD81 P14 cells was reduced in P14 TAP12 (1%) compared to
P14 TAP11(15%) FTOC and could be partially restored by the addition of the RR peptide (3%) at 300 mM.
To examine whether the thymic self-peptides were FTOC correlated with their ability to give rise to antigen-
specific CTLs. Therefore the thymic self peptides incapable of inducing the positive selection of anti-viral
CTL precursors, we induced the positive selection of these experiments induced the positive selection of
functionally competent CD81 thymocytes.CD81 F5 cells or CD81 P14 in TAP12 FTOC with self-
peptide as before, and then used limiting dilution analy-
sis of fetal thymocytes to determine the frequency of Discussion
antigen-specific CTL precursors. The frequency of IF-
68±specific CTL precursors from F5 TAP12 incubated Previous work has clearly demonstrated that the posi-
tive selection of CD81 T cells is peptide specific (Ashton-with HH (0.16%) or BP (0.13%) was about 3-fold higher
than that observed for F5 TAP12 FTOC incubated with Rickardt et al., 1994; Hogquist et al., 1994; Sebzda et
al., 1994). These studies examined the ability of peptide-RR (0.05%). The frequency of LCMV-specific CTL pre-
cursors from P14 TAP12 FTOC incubated with RR antigens and antigen-variants to induce the positive se-
lection of CD81 TCR transgenic thymocytes. While these(1.00%) was about 3-fold higher than that observed for
P14 TAP12 FTOC incubated with HH (0.33%) or RR experiments were important in establishing the parame-
ters governing positive and negative selection of thymo-(0.33%).
These data indicate that the ability of thymic self- cytes, they did not examine how natural self-peptide
ligands trigger the positive selection of thymocytes. Topeptides to generate transgenic CD81 T cells in TAP12
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Figure 5. Differential Ability of Self-Peptides to Induce the Positive
Selection of Transgenic CD81 Thymocytes
(A) The ability of thymic self-peptides (HH, BP, and RR) to restore
the positive selection of CD81 F5 cells was tested in F5 TAP12
FTOC, when added at 300 mM. The peptides BP (5% . p . 1%)
and HH (5% . p . 1%) but not RR (p . 5%) were capable of
generating CD81 F5 cells above the level of F5 TAP12 FTOC incu-
bated alone. There was no significant difference between the abili-
ties of HH and BP to induce the positive selection of CD81 F5 cells
Figure 6. Summary of Self-Peptide Selection Experiments(p . 5%).
(B) The ability of thymic self-peptides to restore the positive selec- (A) The ability of thymic self-peptides (HH, BP, and RR) to restore
tion of CD81 P14 cells was tested in P14 TAP12 FTOC when added the positive selection of CD81 F5 cells was tested in F5 TAP12
at 300 mM. RR gave rise to numbers of CD81 P14 cells above the FTOC, when added at 300 mM. Each point represents the mean
level of P14 TAP12 FTOC incubated alone (1% . p . 0.5%), but number of CD81 F5 cells recovered from thymic lobes from five
HH (p . 5%) and BP (p . 5%) did not. The data represent the separate experiments (four to six independent lobesper experiment,
mean 6 SEM of values obtained from four to six independently as in Figures 4 and 5). The mean value for cell number is indicated
cultured thymi. Similar results were obtained in six other experi- with the SEM. The peptides BP (p , 0.1%) and HH (0.2% . p .
ments. 0.1%) but not RR (p . 5%) were capable of generating CD81 F5
cells above the level of F5 TAP12 FTOC incubated alone. There was
no significant difference between the abilities of HH and BP to
induce the positive selection of CD81 F5 cells (p . 5%). The numberaddress this issue we purified peptides from the class
of CD81 F5 cells recovered from F5 TAP11 FTOC ranged from 16I MHC molecules expressed by thymic epithelial cells
to 59 3 103 cells per lobe (six experiments).and tested their ability to trigger the positive selection
(B) The ability of thymic self-peptides to restore the positive selec-of class I MHC±restricted T cells.
tion of CD81 P14 cells was tested in P14 TAP12 FTOC, when added
Several observations led us to believe that thepositive at 300 mM, over the course of seven separate experiments (as in
selection of CD81 thymocytes is triggered by the spe- A). RR gave rise to numbers of CD81 P14 cells above the level of
P14 TAP12 FTOC incubated alone (1% . p . 0.5%), but HH (p .cific recognition of thymic self-peptides. All of the thymic
5%) and BP (p . 5%) did not. The number of CD81 P14 cellsself-peptides tested were effective in stabilizing H-2Db
recovered from P14 TAP11 FTOC ranged from 17 to 60 3 103 cellsmolecules on the surface of thymic stromal cells in
per lobe (seven experiments).
TAP12 FTOC, but the ability of a self-peptide to induce
the positive selection of CD81 T cells did not depend
solely on the relative density of each self-peptide on with our previous observation that some antigenic pep-
tides, when expressed at high levels in TAP12 FTOC,thymic stromal cells. Although RR was expressed at a
lower density than HH or BP on TAP12 thymic stromal can induce the positive selection of CD81 T cells,
whereas some cannot (Ashton-Rickardt et al., 1993). Thecells, it was the most effective at inducing CD81 cell
positive selection (Figure 3). This finding is consistent relative ability of the self-peptides to induce the positive
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Table 4. Self-Peptides Induce the Positive Selection of Antigen-Specific CTL Precursors
Frequency of Percentage of
Antigen-Reactive Antigen-Reactive
Transgenic TCR FTOC Self-Peptide CTL-P CTL-P
F5 TAP11 Ð 1/80 1.25
TAP12 Ð 1/2000 0.05
TAP12 HH 1/625 0.16
TAP12 BP 1/750 0.13
TAP12 RR 1/2100 0.05
P14 TAP11 Ð 1/12 8.33
TAP12 Ð 1/300 0.33
TAP12 HH 1/300 0.33
TAP12 BP 1/300 0.33
TAP12 RR 1/100 1.00
Using limited dilution analysis, the frequency of anti-IF-68 CTL precursors (CTL-P) was determined from F5 TAP11 and F5 TAP12 thymi
incubated with and without self-peptide, and the frequency of anti-LCMV CTL-P determined from P14 TAP11 and P14 TAP12 thymi incubated
with and without self-peptide. The percentage of CTL-P is the frequency multiplied by 100.
selection of either anti-IF-68 or anti-LCMV CTLs de- of self-peptides for a given TCR may be weak, making
it difficult to measure critical differences in TCR peptide/pended on which TCR was expressed by immature thy-
mocytes in each experiment. For example, HH and BP MHC affinity. The comparison of X-ray structures of vari-
ous self-peptide and antigen-peptide/MHC complexeswere the least effectiveat inducing the positive selection
of anti-LCMV CTLs but the most effective at inducing specific for the same TCR may reveal similarities in
structure that underlie the specificity of self-peptide rec-the positive selection of anti-IF-68 CTLs (Figures 4±6
and Table 4). Conversely, RR was the most effective at ognition during positive selection.
It is unlikely that the positive selection of every CD81inducing the positive selection of anti-LCMV CTLs but
the least effective at inducing the positive selection of T cell relies on the recognition of a unique self-peptide
during thymic development. This is because the diver-anti-IF-68 CTLs (Figures 4±6 and Table 4). These data
are consistent with our previous observations that the sity of self-peptides expressed on thymic stromal cells
would not be sufficient to select a repertoire of T cellspositive selection of CD81 P14 cells is peptide specific
(Ashton-Rickardt et al., 1994). that can respond to peptide antigens derived from a
vast universe of microbial pathogens (Ashton-Rickardt,Taken together, these data are difficult to reconcile
with models of T cell selection that postulate that the 1993). Therefore, it has been argued that the recognition
of self-peptide in positive selection must be relativelyapparent specificity of peptide recognition by TCR dur-
ing positive selection is indirect (Ashton-Rickardt et al., degenerative (Ashton-Rickardt et al., 1993; Martien van
Santen et al., 1995). Support for this view comes from1993; Schumacher and Ploegh, 1994). These models
predict that the ability of a self-peptide to trigger positive several of our observations, as follows.
First, the RR self-peptide when expressed at highselection is governed by its ability not to interfere with
TCR recognition of MHC residues. If this were the case, density on TAP12 thymic stromal cells can effectively
induce the positive selection of a polyclonal populationthen one would have predicted that an individual self-
peptide would have the same effect on the positive se- of CD81 cells. This observation is consistent with earlier
experiments that showed that single peptide/MHC com-lection of thymocytes expressing different TCRs. The
experiments described in this report were conducted plexes can induce the positive selection of polyclonal
CD81 (Ashton-Rickardt et al., 1993) and polyclonal CD41with highly abundant self-peptides expressed by thymic
epithelial cells that together constitute about 20% of thymocytes (Ignatowicz et al., 1996). Therefore a single
peptide/MHC complex can trigger the positive selectiontotal H-2Db associated peptides. Therefore our finding
that these self-peptides are specifically recognized dur- of multiple thymocytes, implying that peptide recogni-
tion is cross-reactive during positive selection. Experi-ing positive selection may be of general significance for
the understanding of positive selection in normal thymi. ments with polyclonal TAP12 FTOC suggest that the
repertoire of CD81 cells selected by RR is larger thanBy expressing abundant self-peptides at high densi-
ties on TAP12 thymic stromal cells, we were able to the repertoire selected by HH or BP (Figure 3). However,
HH and BP could induce the positive selection of anti-demonstrate the differential ability of self-peptides to
induce the positive selection of CD81 cells. This obser- IF-68 CTL precursors in F5 TAP12 FTOC, which occur
at a low frequency in normal thymi (1 in 40,000) (Owenvation implies that the TCR of a given thymocyte will
have a range of different affinities for different self-pep- et al., 1984) and so are not readily detectable in non-
transgenic thymi.tides presented by thymic MHC molecules, and there-
fore if a self-peptide is expressed at the appropriate Second, thymic self-peptides, which have no specific-
ity for P14 or F5 CTLs, can induce the positive selectiondensity it will interact with thymocyte TCR at the appro-
priate avidity to trigger positive selection (Ashton-Rick- of LCMV or IF-68±specific CTL precursors, when ex-
pressed at high density on TAP12 thymic stromal cells.ardt et al., 1994). The comparison of the sequences of
HH, BP, and RR with that of the IF-68 and LCMV antigens Therefore, it appears that thymic self-peptides with a
low affinity for a given TCR, when expressed at highreveals little amino acid homology that correlates with
the ability of each peptide to induce the positive selec- density on thymic stromal cells, can trigger positive se-
lection as long as the appropriate avidity for positivetion of CD81 F5 or CD81 P14 cells. Therefore, the affinity
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C-18 Aquapore column (7 mm inner diameter 3 2.1 mm outerselection is achieved. A similar observation was made
diameter 3 3 cm, Perkin Elmer) with a 65 min gradient of 0% tofor the IF-34peptide (Townsendet al., 1986), whichwhen
15% (5 min), 15 to 60% (50 min), and 60% to 100% (10 min) solventexpressed at high density on TAP12 thymic stromal cells
B in solvent A at a flow rate of 200 ml/min, where solvent B is 0.085%
induced the positive selection of anti-LCMV CTL precur- trifluoroacetic acid and 60% HPLC grade acetonitrile in deionized
sors (Ashton-Rickardt et al., 1994). These experiments water and solvent A is 0.1% trifluoroacetic acid in deionized water.
Fractions were collected at 1 min intervals and frozen on drysuggest that the avidity required for TCR stimulation
ice. Mass spectra were recorded on a Finnigan-MAT TSQ-70 triple-during the positive selection of thymocytes is signifi-
quadrupole mass spectrometer equipped with an electrospray ioncantly lower than that required for TCR stimulation dur-
source and a C-18 microcapillary HPLC column (75 mm inner diame-ing the recognition of antigen by CTLs.
ter 3 175 mm outer diameter) (Hunt et al., 1986). The column was
Third, a population of thymocytes that expresses the eluted with a gradient of 0%±80% acetonitrile in 0.1 M acetic acid
same transgenic TCR (F5) can be positively selected by over 12 min at 0.5 ml/min. The electrospray needle was operated
with a voltage differential of 4.6 keV and a sheath flow of 1.5 ml/mintwo different self-peptides (HH and BP), which share
of a mixture of 7:3 methanol:0.125% acetic acid. The mass range,minimal amino acid homology. In our experiments, the
m/z 300 to 1400, was scanned repetitively every 1.5 sec, and theapparent degeneracy of self-peptide recognition during
total ion signal in each spectra summed.positive selection may explain how the limited repertoire
of thymic self-peptides can select a diverse repertoire
Fetal Thymus Organ Culture (FTOC)of T cells.
TAP12/2 males were mated with females of the same genotype to
Positive selection is thought to be the process by produce TAP12 fetal thymi, and C57BL/6 males were mated with
which the immune system ensures that mature T cells females to produce TAP11 fetal thymi. F51/1TAP12/2RAG12/2 males
can recognize antigen presented on the cell surface by were mated with the females of the same genotype to produce
F51TAP12RAG12 fetal thymi, and F51/1TAP12/2RAG12/2 males wereself-MHC (ªMHC-restricted antigen recognitionº), there-
mated with RAG12/2 females to produce F51TAP11RAG12 fetalby allowing the immune system to respond to intracellu-
thymi. P141/1TAP12/2 males were mated with P141/1TAP12/2 fe-lar pathogens such as viruses. Our findings imply that
males to produce P141TAP12 fetal thymi, and P141/1TAP11/1 males
the specific recognition of self-peptides during positive with P141/1TAP11/1 females to produce P141TAP11 fetal thymi.
selection gives rise to a repertoire of T cells that, in Peptides were synthesized by G. Reddy (The University of Chicago,
addition to being capable of MHC-restricted antigen Cancer Research Oligopeptide Synthesis Facility). RP-HPLC analy-
sis showed that all peptides were more than 95% pure. The concen-recognition, will also be weakly reactive to self-peptides.
tration of peptide was determined by quantitative amino acidHowever, it is difficult to understand why thymic selec-
analysis.tion should give rise to T cells that have the capacity
Fetal thymi (day 16 postcoitum) were cultured according to thefor self-reactivity and so have the potential to give rise method described previously (Ashton-Rickardt et al., 1994). In brief,
to autoimmunedisease. One possible explanation is that dissected fetal thymi were separated into individual lobes and
the ability of mature T cells to participate in low-avidity placed onto 1 cm diameter nitrocellulose filters (0.2 mm pore size).
The filters were then placed on collagen sponges in 2 cm diameterinteractions with self-peptides may be important in en-
dishes and incubated for 9 days at 378C in RPMI 1640 mediumsuring T cell survival in the absence of antigen (Hou et
containing 10% fetal calf serum and peptides. The cultures wereal., 1994; Lau et al., 1994; Bruno et al., 1995). Such
fed every other day by complete medium replacement with fresh
interactions may be important in the maintenance of T peptides.
cell memory, where low-level stimulation of TCR by self-
peptides may be required to ensure antigen-specific
Flow Cytometric Analyses
memory T cell survival in the absence of antigen. If so, The following MAbs were used and purchased from Pharmingen and
then perhaps the role of positive selection is to generate Becton Dickinson: anti-CD4 (allophycocyanin labeled); anti-CD8a
a repertoire of T cells that can cross-react with self- (fluorescein isothiocyanate [FITC] labeled); anti-Va2 (phycoerythrin
[PE] labeled); anti-Vb8.1, 8.2 (biotin labeled); and anti-Vb11 (PE la-peptides in the absence of antigen, thereby ensuring
beled). Staining with anti-Vb8.1, 8.2 was detected by Streptavidin-that the immune system will remember its encounter
conjugated PerCP (Becton Dickinson). Thymocyte suspensionswith antigen.
were prepared from cultured fetal thymi by mechanical desegrega-
tion in fluorescence-activated cell sorter (FACS) buffer (2% fetal calf
serum and 0.1% sodium azide in phosphate-buffered saline) andExperimental Procedures
then incubated with the appropriate MAbs for 30 min at 48C. Cells
were washed and further stained with streptavidin-conjugated fluo-Purification of MHC-Associated Peptides
rochrome for another 20 min to detect MAb-biotin binding. AfterThe MHC-associated peptides were extracted from thymic epithelial
washing, cells were analyzed using a FACSCalibur (Becton Dick-cell line 427.1 by a modified version of a previously described proce-
inson).dure (Hunt et al., 1992). In brief, 427.1 cells were solubilized at 48C
for 1 hr in 20 mM Tris±HCl (pH 8.0), 150 mM NaCl, CHAPS (1%),
phenylmethylsulfonyl fluoride (2 mM), iodoacetamide (100 mM), Determination of CTL Precursor Frequency from FTOC
The antigen-reactive, CTL precursor frequency was estimated usingaprotinin (5 mg/ml), leupeptin (10 mg/ml), pepstatin A (10 mg/ml),
EDTA (3 ng/ml), and sodium azide (0.2%). After centrifugation at limiting dilution analysis, as described previously (Ceredig et al.,
1982). In briefly, thymocyte suspensions (4±6 lobes per suspension)70,000 3 g for 1 hr, supernatants were passed through a 0.2 mm
filter and subjected to affinity chromatographywith 5±10mg of either were incubated at the cell dose of 3±30,000 per well with irradiated
spleen cells from C57BL/6 (106 per well) and rIL-2 (10 U/ml) in micro-anti-H-2Db MAbs B22±249R1 (a1-domain specific) or 28±14±8S (a3-
domain specific) on a 1 ml protein A±Sepharose column. Anti-H- cultures for 7 days. LCMV (for P14) or IF-68 (for F5) was added at
1026 M at the beginning of the culture and on day 5 of culture. After2Dd MAb (34±2±12S) was used to derive a negative-control mock
extract. The extracts were brought to pH 2.0 with 0.2 M glacial 7 days, the microcultures were assayed for cytolytic activity to 51Cr-
labeled RMA target cells (5 3 103 per well) and LCMV (1026 M foracetic acid and boiled for 5 min, cooled to 48C, and then centrifuged
through an Ultrafree-Cl unit (Millipore) with a nominal limit of 5 kDa P14) or IF-68 (1026 M for F5). The cytolytically positive microcultures
were defined as those with 51Cr release values exceeding the meanfor 5 hr at 48C. The peptide filtrate was concentrated using vacuum
centrifugation and then fractionated on a Brownlee narrow-bore spontaneous release by more than 3 times the standard deviation.
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CTL precursor frequency was calculated from the Poisson distribu- Forman, J., Fisher-Lindahl, K., Bevan, M.J., and Monaco, J.J. (1992).
HAM-2 corrects the class I antigen-processing defect in RMA-Stion (Ceredig et al., 1982).
cells. Nature 355, 647±649.
Peptide/MHC Class I Complex Stabilization Analyses Bevan, M.J. (1977). In a radiation chimera, host H-2 antigens deter-
Day 16 fetal thymi were cultured for 3 days with 300 mM peptides mine immune responsiveness of donor cytotoxic cells. Nature 269,
(RR, BP, and HH). The peptides were added at the beginning of 417±418.
culture and on day 2 of culture. On day 3, the thymus lobes were Bjorkman, P.J., Saper, M.A., Bennett, W.S., Strominger, J.L., and
incubated in 0.1% trypsin, 0.5 mM EDTA (GIBCO±BRL) for 40 min Wiley, D.C. (1987). Structure of the human class I histocompatibility
at 378C and digestion stopped by adding FACS buffer. Cells were antigen, HLA-A2. Nature 329, 506±512.
then washed twice and stained with anti-H-2Db (B22.249R1, a1-
Brinster, R.L., Chen, H.Y., Messing, A., van Dyke, T., Levine, A.J.,domain specific) MAbs and a secondary antibody, goat anti-mouse
andPalmiter, R.D. (1984). Transgenic mice harboring SV40 T-antigenimmunoglobulin G (IgG) (FITC labeled). After washing, cells were
genes develop characteristic brain tumors. Cell 37, 367±379.stained with another MAb, anti-I-Ab PE, and then analyzed by FACS.
Bruno, L., Kirberg, J., and von Boehmer, H. (1995). On the cellularTo quantitate the surface expression of H-2Db on gated I-Ab±positive
basis of immunological T cell memory. Immunity 2, 37±43.cells, the fluorescence intensity resulting from staining with anti-H-
2Db MAb was plotted against the relative cell number as described Ceredig, R., Jenkinson, E.J., Mac Donald, H.R., and Owen, J.J.T.
previously (Ashton-Rickardt et al., 1993). The mean level of fluores- (1982). Development of cytolytic T lymphocyte precursors in organ-
cence intensity of anti-H-2Db staining on I-Ab±positive cells was cultured mouse embryonic thymus rudiments. J. Exp. Med. 155,
determined from the resulting histograms. The relative level of H-2Db 617±622.
on stromal cells from TAP12 FTOC incubated with peptide was Faas, S.J., Rothstein, J.L., Kreider, B.L., Rovera, G., and Knowles,
expressed as a percentage of the level observed for stromal cells B.B. (1993). Phenotypically diverse mouse thymic stromal cell lines
TAP11FTOC minus the level for TAP12 cells incubated without pep- which induce proliferation and differentiation of hematopoietic cells.
tide. RMA-S cells (2 3 105 per well) were incubated with serially Eur. J. Immunol. 23, 1201±1214.
diluted peptide (1024±10210 M) for 16 hr at 378C in 96-well microcul- Falk, K., Rotzachke, O., Stevanivic, O., Jung, G., and Rammensee,
ture plates. Cells were then washed twice, stained with anti-H-2Db H.-G. (1991). Allele-specific motifs revealed by sequencing of self-
(B22.249R1) MAb for 30 min at 48C, and detected with a secondary peptides from MHC molecules. Nature 351, 290±296.
MAb, goat anti-mouse-IgG-PE. After washing, RMA-S cells of each
Fecker, L., Ekblom, P., Kurkinen, M., and Ekblom, M. (1990). A geno-peptide dilution were analyzed by FACS. The fluorescence intensity
mic clone encoding a novel proliferation-dependent histone H2A.1resulting from staining with anti-H-2Db MAb was plotted against
mRNA enriched in the poly(A)1 fraction. Mol. Cell. Biol. 10, 2848±peptide concentration. Analysis of peptide concentration at 50%
2854.maximum of titration curve allowed us to determine the relative
Hogquist, K.A., Gavin, M.A., and Bevan, M.J. (1993). Positive selec-ability of each peptide to stabilize the surface expression of peptide/
tion of CD81 T cells induced by major histocompatibility complexMHC class I complexes of RMA-S cells.
binding peptides in fetal thymus organ culture. J. Exp. Med. 177,
1464±1473.CTL Assays
In direct lysis agonist assays, RMA target cells (Ljunggren and Karre, Hogquist, K.A., Jameson, S.C., Heath, W.R., Howard, J.L., Bevan,
1985) (H-2b) were labeled with 51Cr and then plated (5 3 103) with M.J., and Carbone, F.R. (1994). T cell receptor antagonist peptides
F5 or P14 CTLs (1.5 3 104 in 0.2 ml) to give a final effector-to-target induce positive selection. Cell 76, 17±27.
ratio of 3:1. After 4 hr of incubation at 378C, in the presence or Hou, S., Hyland, L., Ryan, K.W., Portner, A., and Doherty, P.C. (1994).
absence of peptide (1025±10212 M), the degree of cytolysis was Virus-specific CD81 T-cell memory determined by clonal burst size.
determined in each well and the percentage specific 51Cr release Nature 369, 652±654.
was calculated as ([experimental release 2 spontaneous release]/
Hunt, D.F., Yates, J.R.D., Shabanowitz, J., Winston, S., and Hauer,
[maximum release 2 spontaneous release]) 3 100. Results are ex-
C.R. (1986). Protein sequencing by tandem mass spectrometry.
pressed as the mean of triplicate determinations. Proc. Natl. Acad. Sci. USA 83, 6233±6237.
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